4D Molecular 制药 FDMT
$12.25 +$1.00 (+8.89%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $12.25 0.00%
开盘$11.46
昨收$11.25
当日区间$11.28 – $12.57
成交量993.3K
市值$676.74M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$3.78M+25,106.7% YoY
营业利润-$77.03M-29.5% YoY
净利润-$72.94M-33.4% YoY
摊薄每股收益-$1.04-6.1% YoY
自由现金流-$70.05M-61.3% YoY
经营现金流-$70.00M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-214.2%
净利率-194.7%
净资产收益率-43.3%
资产收益率-37.1%
投入资本回报率-44.3%
流动比率8.03
负债/资产比率17.2%
现金及投资$361.33M
总负债$33.84M
净现金（净负债）$327.49M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $3.78M | $3.05M | $85.21M | $85.09M | $90,000.00 |
| 营业总收入 | $3.78M | $3.05M | $85.21M | $85.09M | $90,000.00 |
| 营业费用 | $80.81M | $76.67M | $244.76M | $70.38M | $61.28M |
| 销售及管理费用 | $12.52M | $11.69M | $49.06M | $12.77M | $11.84M |
| -管理费用 | $12.52M | $11.69M | $49.06M | $12.77M | $11.84M |
| 研发费用 | $68.28M | $64.98M | $195.70M | $57.61M | $49.44M |
| 营业利润 | -$77.03M | -$73.62M | -$159.55M | $14.72M | -$61.19M |
| 非经营性利息净收入（支出） | $4.26M | $4.86M | $19.48M | $4.70M | $4.33M |
| 非经营性利息收入 | $4.26M | $4.86M | $19.48M | $4.70M | $4.33M |
| 其他收入（支出） | -$166,000.00 | -$4,000.00 | -$37,000.00 | -$22,000.00 | -$21,000.00 |
| 其他非经营性收入（支出） | -$166,000.00 | -$4,000.00 | -$37,000.00 | -$22,000.00 | -$21,000.00 |
| 税前利润 | -$72.94M | -$68.76M | -$140.11M | $19.40M | -$56.88M |
| 净利润 | -$72.94M | -$68.76M | -$140.11M | $19.40M | -$56.88M |
| 持续经营利润 | -$72.94M | -$68.76M | -$140.11M | $19.40M | -$56.88M |
| 归属母公司净利润 | -$72.94M | -$68.76M | -$140.11M | $19.40M | -$56.88M |
| 归属普通股股东净利润 | -$72.94M | -$68.76M | -$140.11M | $19.40M | -$56.88M |
| 基本每股收益 | -$1.04 | -$1.01 | -$2.42 | $0.43 | -$1.01 |
| 摊薄每股收益 | -$1.04 | -$1.01 | -$2.42 | $0.43 | -$1.01 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $492.62M | $512.91M | $566.71M | $566.71M | $423.98M |
| 流动资产合计 | $382.96M | $405.36M | $413.13M | $413.13M | $312.38M |
| 现金及现金等价物与短期投资 | $361.33M | $390.89M | $402.66M | $402.66M | $305.06M |
| -现金及现金等价物 | $70.37M | $72.49M | $60.24M | $60.24M | $48.56M |
| -短期投资 | $290.96M | $318.40M | $342.41M | $342.41M | $256.51M |
| 应收款 | $4.61M | – | – | – | – |
| -其他应收款 | $4.61M | – | – | – | – |
| 其他流动资产 | $17.01M | $14.47M | $10.48M | $10.48M | $7.31M |
| 非流动资产合计 | $109.66M | $107.54M | $153.58M | $153.58M | $111.61M |
| 固定资产净值 | $28.93M | $30.94M | $33.01M | $33.01M | $35.06M |
| -固定资产原值 | $52.37M | $53.49M | $54.29M | $54.29M | $55.12M |
| -累计折旧 | -$23.44M | -$22.55M | -$21.28M | -$21.28M | -$20.06M |
| 投资及预付款 | $69.30M | $66.74M | $111.38M | $111.38M | $67.17M |
| -可供出售证券 | $69.30M | $66.74M | $111.38M | $111.38M | $67.17M |
| 其他非流动资产 | $11.44M | $9.86M | $9.19M | $9.19M | $9.38M |
| 负债合计 | $84.96M | $61.07M | $61.05M | $61.05M | $55.00M |
| 流动负债合计 | $47.67M | $43.40M | $43.99M | $43.99M | $37.11M |
| 应付款 | $12.52M | $14.69M | $11.16M | $11.16M | $6.86M |
| -应付账款 | $12.52M | $14.69M | $11.16M | $11.16M | $6.86M |
| 一年内应计费用 | $25.43M | $22.87M | $26.87M | $26.87M | $24.19M |
| 短期债务及融资租赁负债 | $5.37M | $5.49M | $5.59M | $5.59M | $5.70M |
| -一年内到期融资租赁负债 | $5.37M | $5.49M | $5.59M | $5.59M | $5.70M |
| 一年内递延负债 | $4.35M | $360,000.00 | $360,000.00 | $360,000.00 | $360,000.00 |
| 非流动负债合计 | $37.28M | $17.67M | $17.06M | $17.06M | $17.89M |
| 长期债务及融资租赁负债 | $33.84M | $15.05M | $15.82M | $15.82M | $16.57M |
| -长期债务 | $19.59M | – | – | – | – |
| -长期融资租赁负债 | $14.26M | $15.05M | $15.82M | $15.82M | $16.57M |
| 衍生产品负债 | $384,000.00 | $370,000.00 | $358,000.00 | $358,000.00 | $345,000.00 |
| 一年以上递延负债 | $2.96M | $2.13M | $745,000.00 | $745,000.00 | $835,000.00 |
| 其他非流动负债 | $101,000.00 | $121,000.00 | $138,000.00 | $138,000.00 | $144,000.00 |
| 股东权益合计 | $407.66M | $451.84M | $505.66M | $505.66M | $368.98M |
| 股东权益 | $407.66M | $451.84M | $505.66M | $505.66M | $368.98M |
| 股本 | $6,000.00 | $5,000.00 | $6,000.00 | $6,000.00 | $5,000.00 |
| -普通股 | $6,000.00 | $5,000.00 | $6,000.00 | $6,000.00 | $5,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.27B | $1.24B | $1.22B | $1.22B | $1.10B |
| 留存收益 | -$858.00M | -$785.06M | -$716.30M | -$716.30M | -$735.70M |
| 不影响留存收益的损益 | -$446,000.00 | -$180,000.00 | $727,000.00 | $727,000.00 | $671,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$70.00M | -$68.13M | -$109.08M | $28.55M | -$46.50M |
| 持续经营经营活动现金流净额 | -$70.00M | -$68.13M | -$109.08M | $28.55M | -$46.50M |
| 持续经营净利润 | -$72.94M | -$68.76M | -$140.11M | $19.40M | -$56.88M |
| 持续经营损益 | $57,000.00 | $12,000.00 | -$52,000.00 | $13,000.00 | $11,000.00 |
| 折旧、折耗与摊销 | $2.09M | $2.06M | $7.63M | $1.98M | $2.00M |
| 营运资金变动 | -$4.10M | -$4.75M | $6.17M | $2.76M | $5.00M |
| -预付资产变动 | -$6.53M | -$3.99M | -$424,000.00 | -$3.17M | $2.75M |
| -应付账款及应计费用变动 | $2.49M | -$590,000.00 | $14.93M | $6.67M | $3.15M |
| -其他流动资产变动 | $18,000.00 | -$670,000.00 | -$4.93M | $192,000.00 | $10,000.00 |
| -其他流动负债变动 | -$905,000.00 | -$878,000.00 | -$3.19M | -$850,000.00 | -$814,000.00 |
| -其他营运资金变动 | $830,000.00 | $1.38M | -$209,000.00 | -$90,000.00 | -$90,000.00 |
| 投资活动现金流净额 | $25.54M | $68.89M | -$92.97M | -$128.85M | $17.78M |
| 持续经营投资活动现金流净额 | $25.54M | $68.89M | -$92.97M | -$128.85M | $17.78M |
| 固定资产购置及出售净额 | -$66,000.00 | $11,000.00 | -$536,000.00 | $70,000.00 | $91,000.00 |
| 投资购置及出售净额 | $25.61M | $68.88M | -$92.44M | -$128.92M | $17.69M |
| 筹资活动现金流 | $42.34M | $11.48M | $112.96M | $111.98M | $116,000.00 |
| 持续经营筹资活动现金流净额 | $42.34M | $11.48M | $112.96M | $111.98M | $116,000.00 |
| 普通股发行净额 | $21.84M | $9.81M | $110.72M | $110.72M | $0.00 |
| 股票期权行使所得 | $1.24M | $1.67M | $2.24M | $1.26M | $116,000.00 |
| 期末现金余额 | $70.37M | $72.49M | $60.24M | $60.24M | $48.56M |
| 现金净变动 | -$2.12M | $12.25M | -$89.10M | $11.69M | -$28.60M |
| 期初现金余额 | $72.49M | $60.24M | $149.34M | $48.56M | $77.16M |
| 自由现金流 | -$70.05M | -$68.13M | -$109.62M | $28.62M | -$46.41M |
暂无评论——快来第一个聊聊 FDMT。
登录后参与讨论。